Bioreactor for NHS Blood and Transplant comes from BioLogic Technologies
- NHS Blood and Transplant
- South West
- Open, 1 bid
- 19 January 2026 to 18 January 2031
NHS Blood and Transplant bought a parallel small-scale bioreactor system from BioLogic Technologies Limited, with maintenance and consumables included.
The system is for the Clinical Biotechnology Centre (CBC), which manufactures viral vector products for cell and gene therapies. The CBC expects to take on multiple viral vector projects each year as part of a Medical Research Council funded gene therapy network. Each project goes through process development at small scale first, to pin down its critical process parameters and lower the risk of a failed batch in GMP manufacturing.
The open tender drew one bid, with price counting for 70% of the score, quality 20% and social value 10%. BioLogic won in December 2025 at £811,075, against an estimate of £680,000. The five-year contract runs to January 2031 and could be extended to ten years.
Contract ends January 2031
- What
- Cell analysis and life-science research instruments
- Supplier
- BioLogic Technologies Limited
- Value
- £811,075
- How it was bought
- Open
- 1 bid
- Dates and next
- Jan 2026 to Jan 2031
- Option to Jan 2036